Candidiasis of the Central Nervous System in Neonates and Children with Primary Immunodeficiencies

Rebecca A Drummond1, Michail S Lionakis1

  • 1Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda MD, USA.

Insights

Central nervous system (CNS) candidiasis is a severe infection impacting vulnerable populations. CARD9 deficiency is a key risk factor, highlighting its critical role in fungal defense.

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Central nervous system (CNS) candidiasis poses a life-threatening risk, particularly for neonates and children with primary immunodeficiency disorders (PID).
  • Understanding risk factors for CNS candidiasis is crucial for managing invasive fungal infections in vulnerable patient groups.

Purpose of the Study:

  • To review risk factors for CNS candidiasis.
  • To focus on primary immunodeficiency disorders (PID) linked to CARD9 gene mutations.

Main Methods:

  • Literature review of current knowledge on CNS candidiasis risk factors.
  • Focus on CARD9's role in primary immunodeficiency disorders.

Main Results:

  • CARD9 is essential for protecting the CNS against fungal invasion, promoting neutrophil recruitment and function.
  • CARD9 deficiency is identified as a critical risk factor for CNS candidiasis in humans.

Conclusions:

  • Studying CARD9-deficient patients provides insights into CNS candidiasis pathogenesis applicable to other at-risk individuals, including neonates.
  • Findings support the development of immune-based therapies to combat invasive fungal diseases.
Abstract